Changeflow GovPing Healthcare Formulation and Device for Cosmetic Treatment o...
Routine Notice Added Final

Formulation and Device for Cosmetic Treatment of Onychomycosis

Favicon for changeflow.com EPO Patent Bulletin - Medical Devices (A61M)
Published
Detected
Email

Summary

The European Patent Office published patent application EP4291172A1 by Scholl's Wellness Company LLC for a formulation and device used in cosmetic treatment of onychomycosis (fungal nail infection). The application was published March 25, 2026, with inventors Edmund Farmer and Bruce Nelson. This A1 publication makes the patent application publicly available; no compliance obligations arise from this notice.

What changed

The EPO published patent application EP4291172A1 for a cosmetic formulation and device designed to treat onychomycosis. The applicants are Scholl's Wellness Company LLC, with inventors Edmund Farmer and Bruce Nelson. The application covers IPC classifications including A61K 31/195 (amino acid derivatives), A61K 9/14 (powder formulations), A61M 37/00 (medical device applications), and A61N 5/06 (phototherapy/laser treatments). The patent designates 34 European states.

This publication is informational and does not impose any compliance requirements, deadlines, or penalties. It is relevant primarily for intellectual property tracking, competitive intelligence in the medical device and antifungal treatment space, and freedom-to-operate analysis. No action is required from regulated entities.

Archived snapshot

Apr 1, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

FORMULATION AND DEVICE FOR COSMETIC TREATMENT OF ONYCHOMYCOSIS

Publication EP4291172A1 Kind: A1 Mar 25, 2026

Applicants

Scholl's Wellness Company LLC

Inventors

FARMER, Edmund, NELSON, Bruce

IPC Classifications

A61K 31/195 20060101AFI20241203BHEP A61K 9/14 20060101ALI20241203BHEP A61M 37/00 20060101ALI20241203BHEP A61N 5/06 20060101ALI20241203BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Medical Devices (A61M)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.

Last updated

Classification

Agency
EPO
Published
March 25th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP4291172A1

Who this affects

Applies to
Pharmaceutical companies Manufacturers Healthcare providers
Industry sector
3345 Medical Device Manufacturing 3254 Pharmaceutical Manufacturing
Activity scope
Patent Filing Medical Device Design
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Pharmaceuticals

Get alerts for this source

We'll email you when EPO Patent Bulletin - Medical Devices (A61M) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.